Vir Biotechnology Inc (VIR) stock news · rev $68.6M
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
This VIR news page leads with what Vir Biotechnology Inc filed — not a scraped headline mill.
No cached 8-K sentence for VIR yet. We will not pad this page with generic market recap.
Latest reported VIR revenue for 2025-12-31 was $68.6M. Net income was -$438.0M. Revenue was down 7.6% from 2024-12-31 to 2025-12-31. VIR currently screens at market cap $1.45B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VIR stock page; for the tape open the quote page.
VIR stock news FAQ
What are VIR's latest revenue and net income?
Latest cached Vir Biotechnology Inc (VIR) revenue for Dec 31, 2025 was $68.6M. Net income was -$438.0M. Statements: https://lician.com/financials/vir
How did VIR revenue change from the prior cached period?
Cached Vir Biotechnology Inc (VIR) revenue was down 7.6% from $74.2M (Dec 31, 2024) to $68.6M (Dec 31, 2025). Statements: https://lician.com/financials/vir
What is VIR's market cap?
Vir Biotechnology Inc (VIR) market cap is $1.45B on the latest cached fundamentals snapshot.
What kind of company is VIR?
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Where is VIR stock news listed?
Cached stock news for Vir Biotechnology Inc (VIR) is listed at https://lician.com/news/vir. Filings: https://lician.com/sec/vir
Not investment advice.